|
2009 |
Frontiers proposal. National Institute on Aging "bench to bedside: estrogen as a case study". |
Roberta Diaz Brinton, Ph.D |
|
2009 |
Novel bifunctional peptides as opioid agonists and NK-1 antagonists. |
Tally Largent-Milnes, PhD, Edita Navratilova, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2009 |
Progesterone increases rat neural progenitor cell cycle gene expression and proliferation via extracellularly regulated kinase and progesterone receptor membrane components 1 and 2. |
Roberta Diaz Brinton, Ph.D |
|
2008 |
Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors. |
Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2008 |
Regenerative potential of allopregnanolone. |
Roberta Diaz Brinton, Ph.D |
|
2008 |
The role of COX-2 in heart pathology. |
John M. Streicher, PhD |
|
2008 |
Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2008 |
Progesterone receptors: form and function in brain. |
Roberta Diaz Brinton, Ph.D |
|
2008 |
Intrathecal Raf-1-selective siRNA attenuates sustained morphine-mediated thermal hyperalgesia. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2008 |
Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. |
Roberta Diaz Brinton, Ph.D |
|
2008 |
The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications. |
Roberta Diaz Brinton, Ph.D |
|
2008 |
Estradiol-17beta-induced human neural progenitor cell proliferation is mediated by an estrogen receptor beta-phosphorylated extracellularly regulated kinase pathway. |
Roberta Diaz Brinton, Ph.D |
|
2008 |
Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells. |
|
|
2008 |
Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease. |
Roberta Diaz Brinton, Ph.D |
|
2008 |
DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage. |
|
|
2008 |
Estrogen and hippocampal plasticity in rodent models. |
Roberta Diaz Brinton, Ph.D |
|
2007 |
Profiling of selenomethionine responsive genes in colon cancer by microarray analysis. |
|
|
2007 |
Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma. |
|
|
2006 |
Pharmacogenomics of the polyamine analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl]eicosane tetrahydrochloride, CGC-11093, in the colon adenocarcinoma cell line HCT1161. |
|
|
2006 |
AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells. |
|
|
2006 |
Epigenetic inactivation of the HOXA gene cluster in breast cancer. |
|
|
2005 |
Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD. |
Jeffrey J. Lochhead, PhD |
|
2005 |
Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. |
Jeffrey J. Lochhead, PhD |
|
2005 |
Serotonin-related gene expression in female monkeys with individual sensitivity to stress. |
John M. Streicher, PhD |
|
2005 |
Water Quality and Cholesterol-induced pathology: differential effects of the M-1 muscarinic receptor agaonist AF267b on accumulation of Alzheimer-like Amyloid B in rabbit brain |
Jeffrey J. Lochhead, PhD |
